GlassScriptPhysician profile
William Jackson Perkins
NPI 1871813733
$2,357.04
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $451 · 2020: $1,120 · 2021: $224 · 2022: $196 · 2023: $252 · 2024: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $978.92 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $428.73 | 2019-2020 | |
| Ambu INC. | $179.89 | 2020-2021 | |
| Boston Scientific Corporation | $105.34 | 2021 | |
| Horizon Therapeutics Plc | $101.74 | 2022 | |
| Janssen Biotech, INC. | $76.96 | 2020 | |
| Novo Nordisk INC | $75.46 | 2022 | |
| Ironwood Pharmaceuticals, INC | $70.46 | 2020-2021 | |
| Braintree Laboratories, INC. | $39.10 | 2023 | Sutab, Suflave |
| Allergan, INC. | $35.68 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.52 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $35.11 | 2023 | Dupixent |
| Nestle Healthcare Nutrition INC. | $32.02 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $29.19 | 2023-2024 | Voquezna |
| Merck Sharp & Dohme LLC | $27.13 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $24.12 | 2024 | Rebyota |
| Daiichi Sankyo INC. | $22.24 | 2020 | |
| Shire North American Group INC | $18.99 | 2019 | |
| Celgene Corporation | $16.35 | 2023 | Zeposia |
| Intercept Pharmaceuticals, INC. | $13.53 | 2020 | |
| Qol Medical, LLC | $10.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Perkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.